Oliver Spandow - Dec 14, 2021 Form 4 Insider Report for NEPHROS INC (NEPH)

Role
Director
Signature
/s/ Christopher Melsha as attorney-in-fact for Oliver Spandow pursuant to power of attorney previously filed.
Stock symbol
NEPH
Transactions as of
Dec 14, 2021
Transactions value $
$0
Form type
4
Date filed
12/16/2021, 08:16 PM
Next filing
Jan 9, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEPH Common Stock Award $0 +5.43K +27.98% $0.00 24.8K Dec 14, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NEPH Stock Option (Right to Buy) Award $0 +7.06K $0.00 7.06K Dec 14, 2021 Common Stock 7.06K $6.82 Direct F4
holding NEPH Stock Option (Right to Buy) 9.47K Dec 14, 2021 Common Stock 9.47K $5.58 Direct F2
holding NEPH Stock Option (Right to Buy) 5.16K Dec 14, 2021 Common Stock 5.16K $5.85 Direct F2
holding NEPH Stock Option (Right to Buy) 5.57K Dec 14, 2021 Common Stock 5.57K $8.57 Direct F2
holding NEPH Stock Option (Right to Buy) 6.85K Dec 14, 2021 Common Stock 6.85K $8.06 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of restricted stock granted to the reporting person in lieu of cash fees payable to the reporting person for his service on the Company's Board of Directors. These shares of restricted stock vest 6 months following the grant date.
F2 Fully exercisable.
F3 This option vests as to 2,284 shares on 1/6/21 and as to 2,283 shares on each of 1/6/22 and 1/6/23.
F4 Represents options granted to the reporting person for his service on the Company's Board of Directors. This option vests as to 2,354 shares on each of 12/14/21, 12/14/22 and 12/14/23.